DarioHealth Corp. (DRIO) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Stockholders held by DarioHealth Corp. on December 18, 2024. The company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol DRIO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1: Election of Directors - All seven nominees were elected. Significant broker non-votes (6,671,020 shares) were recorded for each director, indicating shares held by brokers that were not voted due to lack of instructions.
- Proposal 2: Ratification of Auditors - Stockholders ratified the appointment of Kost Forer Gabbay & Kasierer (a member of Ernst & Young Global) as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and the percentage of shares represented by the 6,671,020 broker non-votes to assess shareholder engagement levels.
- Confirm the specific terms of the engagement with the newly ratified auditor, Kost Forer Gabbay & Kasierer.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.